Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human-Derived Mesenchymal Stem Cell Conditioned Medium for Pain
jRCT1051250201Recruiting
- Sponsor
- Jingu Gaien Woman Life Clinic
- Start
- Jan 2026
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of human-derived mesenchymal stem cell conditioned medium in pain, sponsored by Jingu Gaien Woman Life Clinic. Primary endpoints: Impact of pain on daily life, Pain pattern and 3 more. Started Jan 2026; status: recruiting.
02
Drugs
human-derived mesenchymal stem cell conditioned medium
03
Conditions
pain
Beyond the preview
Go deeper on jRCT1051250201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051250201.